YN290360 GW1929 196808-24-9

GW1929 is a potentPPAR-γagonist, with a pKi of 8.84 for humanPPAR-γ, and pEC50s of 8.56 and 8.27 for humanPPAR-γ and murinePPAR-γ, respectively.

YN370362 CD3254 196961-43-0

CD3254 a potent and selective retinoid-X-receptor (RXR) agonist.

YN370033 RPR107393 free base 197576-78-6

RPR107393 free base is a selectivesqualene synthaseinhibitor, which inhibits rat liver microsomal squalene synthase with an IC50 of 0.8nM.

YN370112 CDD3506 197913-15-8

CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepaticcytochrome P450IIIA (CYP3A)activity.

YN1720044 GIP (1-30) amide,Human 198624-01-0

GIP (1-30) amide,Human is a glucose-dependent insulinotropic polypeptide (GIP) fragment. GIP is an incretin hormone that stimulates insulin secretion and reduces postpr and ial glycaemic excursions. GIP (1-30) amide (Human) ...

YN290381 Balaglitazone 199113-98-9

Balaglitazone is a selective partialPPARγagonist with an EC50 of 1.351μM for humanPPARγ.

YN371149 Dihydroxyfumaric acid hydrate 199926-38-0

Dihydroxyfumaric acid hydrate is an endogenous metabolite.

YN270340 Omigapil maleate 200189-97-5

Omigapil maleate, an orally bioavailableGAPDH nitrosylationinhibitor, abrogates Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice. Omigapil maleate has the potential for the research of Alzheim...

YN484148 Leptin (93-105), human 200436-43-7

Leptin (93-105), human, is the amino acids 93 to 105 fragment of human leptin. Leptin is a 167-residue peptide hormone mainly produced by adipocytes and acts in the central nervous system to primarily coordinate the metabolic adaptation...

YN1720019 Glucagon receptor antagonists... 202917-17-7

Glucagon receptor antagonists-3 is a highly potent glucagon receptor antagonist.

YN1720018 Glucagon receptor antagonists... 202917-18-8

Glucagon receptor antagonists-2 is a highly potent glucagon receptor antagonist.

YN480047 FR194738 free base 204067-45-8

FR194738 free base is asqualene epoxidaseinhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8nM.

YN480048 FR194738 204067-52-7

FR194738 is asqualene epoxidaseinhibitor. FR194738 inhibits squalene epoxidase activity in HepG2 cell homogenates with an IC50 of 9.8nM.

YN320792 LY377604 204592-94-9

LY377604 is ahuman β3-adrenergic receptoragonist with an EC50 of 2.4nM and also aβ1- and β2-adrenergic receptorantagonist.

YN1720025 Liraglutide 204656-20-2

Liraglutide is aglucagon-like peptide-1(GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.

YN483715 Korepimedoside C 205445-00-7

Korepimedoside C (Epimedin I), a flavonol glycoside, is isolated from the aerial parts ofEpimedium koreanumNakai.Epimedium koreanumNakai is a famous Chinese herbal medicine for the research of impotence, osteoporosis, immune suppre...

YN290118 Locked nucleic acid 1 206055-71-2

Locked nucleic acid 1 is a derivative of LNA-type nucleoside.

YN321176 BD1063 dhydrochloride 206996-13-6

BD1063 dhydrochloride is a potent and selectivesigma 1 receptorantagonist.

YN484238 NNC45-0781 207277-66-5

NNC45-0781 is a tissue-selectiveestrogenpartial-agonist.

YN373353 D-Glucuronic acid sodium sal... 207300-70-7

D-Glucuronic acid sodium salt monohydrate is an endogenous metabolite.